Post Eradication Assessment of Hepatic ‎Fibrosis in Hepatitis C

Study of Fibro Q Index as a Non invasive Method to Predict Liver Fibrosis in Chronic Hepatitis C

Effect of viral load on hepatic fibrosis in patients with chronic hepatitis B patients: assessed by fibroscan

Liver Fibrosis Assessment in Cases of Chronic Hepatitis C after Direct Acting Antivirals Therapy using Aspartate Aminotransferase to Platelet Ratio Index and Transient Elastograph

Non-invasive Evaluation of Liver Fibrosis Changes in Patients with Chronic ‎Hepatitis C after Directly Acting Antiviral Drugs

Assessment of Degree of Fibrosis in Chronic Hepatitis C Virus Patients Treated with Direct Acting Antiviral Agents

Evaluating the effect of direct-acting agents on liver fibrosis, by real-time elastography, Fibroscan and FIB4 score in chronic HCV patients

Assessment of Fibrosis After Treatment with Direct-Acting Antiviral Drugs with or without Silymarin in Patients with Chronic Hepatitis C Related Liver Disease

Evaluation of fibroscan as a predictor of risk of hepatocellular carcinoma in hepatitis C patients

Fibroindex, a simple noninvasive test forprediction of fibrosis in patients withchronic hepatitis C virus infection